NCT03801252View on ClinicalTrials.gov

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
ObesityInduction of Labor Affected Fetus / Newborn
Interventions
DRUG

Cefazolin

intravenous drugs used as prophylactic antibiotics

DRUG

Placebo

Intravenous saline

DRUG

Azithromycin

prophylactic antibiotic

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT03801252 - Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term | Biotech Hunter | Biotech Hunter